[Journal clubs] Mar 27,2025 [Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer]

Guo, X., Nie, H., Zhang, W., Li, J., Ge, J., Xie, B., Hu, W., Zhu, Y., Zhong, N., Zhang, X., Zhao, X., Wang, X., Sun, Q., Wei, K., Chen, X., Ni, L., Zhang, T., Lu, S., Zhang, L., & Dong, C. (2025). Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer. Cancer cell, 43(2), 248–268.e9. https://doi.org/10.1016/j.ccell.2025.01.001

발표날짜: 2025.03.27.

발표자: 조유빈